Insurer Directory Find Your Insurance Company Select your insurer below to see coverage policies, prior authorization requirements, and tips for getting approved
Department of Health and Human Services, FDA is charged with overseeing the safety of many products
Manipulating bacterial communities by in situ microbiome engineering
Under 24 hours Prescription issued in under 24 hours if approved
Rhizosphere interactions: root exudates, microbes, and microbial communities
Retatrutide Half-life: ~68 days Dosing: Once weekly subcutaneous injection Profile: Triple receptor activity supports more dramatic weight loss outcomes, with sustained pharmacologic coverage across the dosing interval Why the Comparison Matters While Retatrutides half-life is similar to semaglutide and tirzepatide, its efficacy appears greater because of its triple agonism